Conference abstract · 15 Mar 2017
Conference abstractPublished 15 Jun 2026
Pulmonary Artery Dilation Secondary to Severe Pulmonary Hypertension
University of Texas at Tyler Health Science Center, United States
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pulmonary hypertension (PH) is a complex condition characterized by elevated blood pressure in the arteries of the lungs, leading to increased strain on the heart. This case highlights a 49-year-old African American female with a constellation of comorbidities including hypertension, obstructive sleep apnea, heart failure with preserved ejection fraction (HFpEF), and chronic hypoxic respiratory failure, all contributing to her severe presentation. Her symptoms, worsening lower extremity edema and dyspnea, are classic indicators of PH and right heart strain, ultimately necessitating emergent intubation and mechanical ventilation. Diagnostic imaging, specifically a CT pulmonary angiogram, revealed significantly enlarged pulmonary arteries, strongly suggestive of chronic pulmonary arterial remodeling. Further invasive assessment through right heart catheterization confirmed severe mixed pulmonary hypertension, classified as both pre- and post-capillary (WHO Group 2/3). This mixed presentation indicates that her PH was driven by a combination of factors, including her underlying left-sided heart failure (post-capillary component) and potentially intrinsic pulmonary vascular disease (pre-capillary component). Her management involved aggressive interventions such as intravenous diuresis to reduce fluid overload, inhaled nitrous oxide for pulmonary vasodilation, and epoprostenol, a potent prostacyclin analog, to lower pulmonary artery pressures. While she showed initial improvement, her inability to sustain extubation underscored the severity and refractory nature of her PH, complicated by multiple underlying health issues. This case critically emphasizes that mixed pulmonary hypertension demands a multifaceted approach to diagnosis and treatment, often challenging to manage despite advanced therapies, ultimately leading to difficult decisions regarding comfort care.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
Similar by topic
Research article · 2015
Response to Inhaled Nitric Oxide, But neither Sodium Nitroprusside nor Sildenafil, Predicts Survival in Patients with Dilated Cardiomyopathy Complicated with Pulmonary Hypertension
Research article · 30 Nov 2023
Pulmonary Expression of Non-Canonical Wnt Signaling is Upregulated in Pulmonary Hypertension Secondary to Left Ventricular Dysfunction
Commentary · 5 Mar 2025
Novel Therapeutics for Pulmonary Arterial Hypertension: Targeting Disease Pathways beyond Vasodilation
Conference abstract · 21 Oct 2021
Autoantibody Clustering in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension
More from this journal
The newest in Clinical and Experimental Cardiology.
Short communication · 4 Aug 2026
An effective determination method for aortic valve replacement through minimally invasive lower median sternotomy
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Christos Sarantopoulos”
